Theralase® Technologies Inc.
OTC TLTFF · Toronto Ontario, Ontario, Canada
Works in Oncology · Renal & urogenital · Women's health
Theralase® Technologies Inc. is a clinical trial sponsor based in Toronto Ontario, Ontario, Canada, listed as OTC TLTFF. It has 1 active clinical trial with 90 planned participants, in Oncology, Renal & urogenital and Women's health.
Trial track record · since 2021
Financials · OTC TLTFF
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Theralase® Technologies Inc
Theralase® Technologies Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 90 planned participants, in Oncology, Renal & urogenital, Women's health. Since 2021 it has completed 0 trials and stopped 0 early.
Theralase® Technologies Inc is based in Toronto Ontario, Ontario, Canada and is listed as OTC TLTFF. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Theralase® Technologies Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-11-24.
Approve Suite is not affiliated with Theralase® Technologies Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.